10:06 AM EST - Microbix Biosystems Inc. : Announces a collaboration with Ulisse Biomed S.p.A. a company developing innovative diagnostics, theranostics, and therapeutics. The companies are collaborating to make Microbix’s Quality Assessment Products available and optimized to support the clinical use and accuracy of Ulisse molecular tests for high-risk types of Human Papilloma Virus. Microbix Biosystems Inc.
shares T.MBX are trading down $0.01 at $0.24.
